Teva Pharmaceutical Industries reported $252M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 0 Jun/2024
Cipla 140.5M 300K Jun/2025
Dr.Reddys Laboratories 830M 174M Jun/2025
Guangzhou Baiy CNY 101.61M 142.6M Mar/2025
Jiangsu Hengrui CNY 2.25M 2.25M Dec/2024
Kalbe Farma IDR 10.38B 8.98B Jun/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sh Fosun Pharma CNY 329.53M 28.8M Mar/2025
Sun Pharmaceuticals 748M 256.6M Jun/2025
Teva Pharmaceutical Industries USD 252M 40M Jun/2025